ON THE MECHANISM OF KETONIC DECARBOXYLATION PYROLYSIS OF CALCIUM DECANOATEHITES RA; BIEMANN K.1972; J. AMER. CHEM. SOC.; U.S.A.; DA. 1972; VOL. 94; NO 16; PP. 5772-5777; BIBL. DISSEM.Serial Issue

A DEPOT NEUROLEPTIC WITHDRAWAL STUDY. A CONTROLLED STUDY OF THE CLINICAL EFFECTS OF THE WITHDRAWAL OF DEPOT FLUPHENAZINE DECANOATE AND DEPOT FLUPENTHIXOL DECANOATE IN CHRONIC SCHIZOPHRENIC PATIENTSWISTEDT B.1981; ACTA PSYCHIATR. SCAND.; ISSN 0001-690X; DNK; DA. 1981; VOL. 64; NO 1; PP. 65-84; BIBL. 2 P.Article

FLUPHENAZINE DECANOATECLARKE G.1980; ANAL. PROFILES DRUG SUBST.; ISSN 0099-5428; USA; DA. 1980; VOL. 9; PP. 275-294; BIBL. 37 REF.Article

Amphetamine-induced aggression is enhanced in rats pre-treated with the anabolic androgenic steroid nandrolone decanoateSTEENSLAND, Pia; HALLBERG, Mathias; KINDLUNDH, Anna et al.Steroids. 2005, Vol 70, Num 3, pp 199-204, issn 0039-128X, 6 p.Article

Nandrolone-pretreatment enhances cardiac β₂-adrenoceptor expression and reverses heart contractile down-regulation in the post-stress period of acute-stressed ratsPENNA, Claudia; ABBADESSA, Giuliana; MANCARDI, Daniele et al.Journal of steroid biochemistry and molecular biology. 2007, Vol 107, Num 1-2, pp 106-113, issn 0960-0760, 8 p.Article

Nandrolone decanoate transformation by Neurospora crassaMOJTABA TABATABAEI YAZDI; AMANI, Amir; MOHAMMAD ALI FARAMARZI et al.Pharmaceutical biology. 2005, Vol 43, Num 7, pp 630-635, issn 1388-0209, 6 p.Article

The prevalence of depot neuroleptic treatment among West Indians and Asians in the London borough of NewhamGLOVER, G; MALCOLM, G.Social psychiatry and psychiatric epidemiology (Print). 1988, Vol 23, Num 4, pp 281-284, issn 0933-7954Article

High doses of nandrolone decanoate reduce volume of testis and length of seminiferous tubules in ratsNOORAFSHAN, Ali; KARBALAY-DOUST, Saied; FAKHRODIN MESBAH ARDEKANI et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2005, Vol 113, Num 2, pp 122-125, issn 0903-4641, 4 p.Article

L'étude des concentrations plasmatiques des neuroleptiques à action prolongée dans le traitement des psychoses chroniques = Serum level assays of long acting neuroleptics in the management of chronic psychosesGIRARD, M; GRANIER, F; GARDES, J. P et al.La Semaine des hôpitaux de Paris. 1985, Vol 61, Num 14, pp 929-933, issn 0037-1777Article

Nandrolone decanoate and load increase remodeling and strength in human supraspinatus bioartificial tendonsTRIANTAFILLOPOULOS, Ioannis K; BANES, Albert J; BOWMAN, Karl F et al.American journal of sports medicine. 2004, Vol 32, Num 4, pp 934-943, issn 0363-5465, 10 p.Article

COMPARISON OF ANTIPSYCHOTIC DEPOT INJECTIONS IN THE MAINTENANCE TREATMENT OF SCHIZOPHRENIA.CARNEY MWP; SHEFFIELD BF.1976; BRIT. J. PSYCHIATRY; G.B.; DA. 1976-11; VOL. 129; PP. 476-481; BIBL. 10 REF.Article

Experimental and Modeling Investigation of n-Decane Pyrolysis at Supercritical PressuresZHENJIAN JIA; HONGYAN HUANG; WEIXING ZHOU et al.Energy & fuels. 2014, Vol 28, Num 9-10, pp 6019-6028, issn 0887-0624, 10 p.Article

Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletesHARTGENS, F; CHERIEX, E. C; KUIPERS, H et al.International journal of sports medicine. 2003, Vol 24, Num 5, pp 344-351, issn 0172-4622, 8 p.Article

ELECTROPHYSIOLOGICAL STUDY OF A NEW LONG.-ACTING NEUROLEPTIC, NOROXYCLOTHEPIN DECANOATE1973; ACTIV. NERV. SUP.; TCHECOSL.; DA. 1973; VOL. 15; NO 2; PP. 82-83; BIBL. 4REF.; (XV TH. ANNU. PSYCHOPHARMACOL. MEET.; JESENIK; 1973)Conference Paper

Evidence that antioxidants prevent the inhibition of Na⁺, K⁺-ATPase activity induced by octanoic acid in rat cerebral cortex in vitroDE ASSIS, Dênis R; RIBEIRO, César A. J; WAJNER, Moacir et al.Neurochemical research. 2003, Vol 28, Num 8, pp 1255-1263, issn 0364-3190, 9 p.Article

KINETICS OF THERMAL DECOMPOSITION OF COPPER SOAPSMEHROTRA KN; MEHTA VP; NAGAR TN et al.1973; Z. NATURFORSCH., B; DTSCH.; DA. 1973; VOL. 28; NO 1-2; PP. 90-92; BIBL. 2 REF.Serial Issue

NOROXYCLOTHEPIN DECANOATE (VUFB-9976) LONG ACTING NEUROLEPTIC DRUGKAZDOVA E; DLABAC A.1973; ACTIV. NERV. SUP.; TCHECOSL.; DA. 1973; VOL. 15; NO 2; PP. 81-82; BIBL. 2REF.; (XVTH. ANNU. PSYCHOPHARMACOL. MEET.; JESENIK; 1973)Conference Paper

Interfacial Behavior of n-Decane Bound to Weakly Hydrated Silica Gel and Nanosilica over a Broad Temperature RangeTUROV, Vladimir V; GUN'KO, Vladimir M; ZARKO, Vladimir I et al.Langmuir. 2013, Vol 29, Num 13, pp 4303-4314, issn 0743-7463, 12 p.Article

ANALYSIS OF THE ANDROGEN RESPONSE OF 23 PATIENTS WITH AGNOGENIC MYELOID METAPLASIA. THE VALUE OF CHROMOSOMAL STUDIES IN PREDICTING RESPONSE AND SURVIVALBESA EC; NOWELL PC; GELLER NL et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 2; PP. 308-313; BIBL. 29 REF.Article

MODIFICATION DE LA COAGULABILITE SANGUINE PAR ADMINISTRATION PROLONGEE DE RETABOLYLSAVEL'EVA AV.1973; FARMAKOL. I TOKSIKOL.; S.S.S.R.; DA. 1973; VOL. 36; NO 3; PP. 332-334; ABS. ANGL.; BIBL. 13REF.Serial Issue

ACTION DU DECANOATE DE FLUPENTIXOL DANS LES PSYCHOSES CHRONIQUES DE TYPES SCHIZOPHRENIQUESEVRARD E; HEUSGHEM C; MOLDERS V et al.1972; ACTA PSYCHIATR. BELG.; BELG.; DA. 1972; VOL. 72; NO 5; PP. 573-594; ABS. NEERL. ANGL. ALLEM. ITAL. ESP.; BIBL. 1P.Serial Issue

CONTRIBUTION A L'ETUDE CLINIQUE D'UN NEUROLEPTIQUE RETARD EN PRATIQUE PSYCHIATRIQUE: LE DECANOATE DE FLUPHENAZINECOMBRICHON C.1972; ; S.L.; DA. 1972; PP. 1-81; BIBL. 4 P. 1/2; (THESE DOCT. MED.; UNIV. CLAUDE BERNARD LYON; 1972)Thesis

Surface fractionation of multicomponent oil mixturesPETERSON, J. W; BERG, J. C.Industrial & engineering chemistry fundamentals. 1986, Vol 25, Num 4, pp 668-677, issn 0196-4313Article

EARLY HOSPITAL EXPERIENCE WITH FLUPHENAZINE DECANOATE. = DEBUT DE L'EXPERIMENTATION DU FLUPHENAZINE DECANOATE EN MILIEU HOSPITALIERSMALL JG; KELLAMS J.1974; DIS. NERV. SYST.; U.S.A.; DA. 1974; VOL. 35; NO 10; PP. 453-456; BIBL. 23 REF.Article

VORSCHLAEGE ZUM DEUTSCHEN ARZNEIBUCH, 7-AUSGABE: DESCAMETHASON, NANDROLONDEKANOAT UND NANDROLONPHENYLPROPIONAT = PROPOSITIONS POUR LE DAB 7: DEXAMETHASONE, DECANOATE ET PHENYLPROPIONATE DE NANDROLONEGANSHOW S; SEIDENGLANZ G.1972; ZBL. PHARM. PHARMAKOTHERAP. LAB.-DIAGNOST.; DTSCH.; DA. 1972; VOL. 111; NO 9; PP. 961-967Serial Issue